Christopher J. Rigell

Statistics

Publications

Citations

162

H-Index

Active since

2008

Affiliations

University of Alabama at Birmingham(Current)

Washington University in St. Louis

Christopher J. Rigell is an author at University of Alabama at Birmingham specializing in pharmacology, monoclonal antibodies in oncology, and oncology.

Publications per year

2008–2022

Publications

Ataxia Telangiectasia-Mutated Damage-Signaling Kinase- and Proteasome-Dependent Destruction of Mre11-Rad50-Nbs1 Subunits in Simian Virus 40-Infected Primate Cells

Xiaorong Zhao, Ramiro J. Madden‐Fuentes, Becky X. Lou et al. · Journal of Virology · 2008 · 105 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Dual Combination Therapy Targeting DR5 and EMMPRIN in Pancreatic Adenocarcinoma

Hyunki Kim, Guihua Zhai, Sharon Samuel et al. · Molecular Cancer Therapeutics · 2011 · 21 citations · Full text

Medicine, Oncology, Pharmacology +10

mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes

Ofer Zimmerman, Alexa Michelle Altman Doss, Paulina Kapłonek et al. · Cell Reports Medicine · 2022 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers

Hyunki Kim, Christopher J. Rigell, Guihua Zhai et al. · Molecular Imaging and Biology · 2013 · 10 citations

Medicine, Oncology, Pharmacology +15

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

Frank J. Lin, Alexa Michelle Altman Doss, Hannah G. Davis-Adams et al. · Frontiers in Immunology · 2022 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 5